Quick Info
| Profession | Entrepreneur, Biologist, Biotechnologist |
|---|---|
| Nationality | American |
| Date of Birth | 28/07/1973 |
| Age | 53 years |
| Birthplace | San Mateo, California, USA |
| Zodiac Sign | Leo |
Latest News about Anne Wojcicki
The 23andMe Research Institute announced its inaugural Scientific Advisory Board, a group of scientific leaders who will advise on research priorities, program design, grant applications, and partnerships at the intersection of genomics, artificial intelligence, and healthcare. Anne Wojcicki, Founder and CEO of the Institute, described the board as an extraordinary group that will help unravel the mysteries of the human genome.
A landmark study made possible by the 23andMe Research Institute identified a powerful inherited variant linked to lung cancer risk. The research grew out of work begun in 2019 by a Dana-Farber Cancer Institute researcher who approached the company about a genetic variant.
Anne Wojcicki's nonprofit organization, TTAM Research Institute, won a bankruptcy auction to acquire 23andMe for $305 million, surpassing a $256 million bid from Regeneron Pharmaceuticals. The deal, pending court approval, grants TTAM control of substantially all 23andMe assets, including its personal genome service, research services, and Lemonaid Health telehealth initiative.
Anne Wojcicki resigned as CEO of 23andMe effective March 24, 2025, shortly after the company filed for Chapter 11 bankruptcy. She remained on the company's board while the personal genomics firm navigated severe financial challenges and sought to restructure its operations.
Do you like Anne Wojcicki?
You can vote only once.
83% like · 17% dislike
Bio/Wiki
| Summary | American entrepreneur and biologist who co-founded 23andMe, a personal genomics company providing direct-to-consumer DNA testing for ancestry and health risk analysis. Pioneer in democratizing access to genetic information for personalized medicine and research. She now leads the 23andMe Research Institute as founder and CEO following the 2025 acquisition of the company's assets. |
|---|
Physical Stats & More
| Residence | Los Altos, California |
|---|
Educational Qualification(s)
| Undergraduate | B.S. in Biology, Yale University (1996) |
|---|
Personal Life
| |||||||
| |||||||
Relationships & More
| |||||||
| |||||||
Family
| |||||
Career
| Background | 10 years in healthcare investing, focused on biotechnology companies; worked as researcher and investment analyst |
|---|---|
| Founding | Co-founded 23andMe in April 2006 with Linda Avey and Paul Cusenza |
| Role | Co-founder of 23andMe (2006–present); Former CEO (2006–March 24, 2025) |
| Company Milestone | 23andMe served over 13 million people and built the second-largest genetic database in the world |
| Public Offering | Took 23andMe public via SPAC, raising approximately $600 million |
| Recent Events | Resigned as CEO effective March 24, 2025 following company's Chapter 11 bankruptcy filing; TTAM Research Institute (led by Wojcicki) regained control of 23andMe on June 13, 2025 through $305 million acquisition deal; the business now operates as the 23andMe Research Institute |
| Recognition | Time Magazine named 23andMe's genetic testing kit Invention of the Year in 2008 |
| Current Position | Founder and CEO of the 23andMe Research Institute (2025–present) |
Some Lesser Known Facts
| 1. Visited Poland during a gap year between high school and college | |
| 2. Motivated by personal ambition to access and understand her own genetic information | |
| 3. Founded 23andMe following the human genome mapping completion in 2003 | |
| 4. 23andMe's early marketing included celebrity-hosted spit parties at New York Fashion Week and a promotional blimp over Silicon Valley |
Social Media